Paul Lockman, Ph.D.
Paul Lockman isn’t a medical doctor. He’ll be the first to tell you that. Although he trained as a nurse and spent years working in neonatal intensive care, he considers himself a scientist first and foremost. With a PhD in pharmaceutical sciences and an aptitude for complex math, he spent his time in graduate school studying how drugs move through the brain, not cancer.
Lori Hazlehurst, Ph.D.
Dr. Hazlehurst, a professor in the WVU School of Pharmacy Department of Pharmaceutical Sciences and co-leader of the Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program at the WVU Cancer Institute, specializes in researching hematologic malignancies—cancers that affect the blood and bone marrow, such as myeloma, acute myeloid leukemia (AML), and chronic myeloid leukemia (CML). These cancers originate in the bone marrow where platelets and red and white blood cells are manufactured.